September 2011

KJZZ's Steve Goldstein asks Arizona Commerce Authority CEO Don Cardon how the public-private partnership will bring jobs to Arizona.
September 09, 2011
   KJZZ's Morning Edition Host Dennis Lambert spoke with US Secretary of Housing and Urban Development Shaun Donovan about the impact of the President Obama's Jobs speech on Arizona homeowners.
September 09, 2011
Lisa Schnebly Heidinger, native Arizonan and author of Arizona: 100 Years Grand, talks to host Steve Goldstein about the state's upcoming centennial and publishing the book celebrating 100 years of state history.
September 07, 2011
Former Phoenix Mayor and former Attorney General Terry Goddard talks to host Steve Goldstein about the condition of politics in Arizona and what leaders need to focus on to make the state thrive.
September 07, 2011
NPR White House correspondent Scott Horsley joins host Steve Goldstein to preview President Obama's Thursday address about the nation's job market. Robert Mittelstaedt, Dean of the W.P. Carey School of Business at ASU, talks to Goldstein about unemployment and job creation in the U.
September 07, 2011
       NPR News captures the national memorial ceremonies from ground zero, the Pentagon and Shanksville, with nine hours of live coverage hosted by Weekend Edition host Audie Cornish and Talk of the Nation host Neal Conan.
September 06, 2011
A drug that caused severe birth defects 50 years ago is now undergoing a clinical trial in the valley.The Banner Sun Health Research Institute in Sun City is conducting a study of Thalodomide to see if it can stop the progression of Alzheimer's disease.
September 06, 2011
KJZZ's Theatre Critic Robrt Pela reviews Nearly Naked Theatre's production of Oedipus for Kids which runs through September 10th.Robrt Pela is a columnist at New Times and a staff writer at Latino Perspectives Magazine.
September 02, 2011
A drug that caused severe birth defects 50 years ago is undergoing a clinical trial in the valley.  The Banner Sun Health Research Institute in Sun City is conducting a study of thalidomide to see if it can stop the progression of Alzheimer’s disease.
September 01, 2011

Pages